This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-IL17F monoclonal antibody, clone 5I2730 [Biotin]
catalog :
DCABH-4121
quantity :
100 μg
clonality :
monoclonal
host :
mouse
conjugate :
biotin
clone name :
5I2730
reactivity :
human
application :
western blot, immunohistochemistry - paraffin section
product information
Cat :
DCABH-4121
Product Name :
Anti-IL17F monoclonal antibody, clone 5I2730 [Biotin]
Brand :
Creative Diagnostics
Abbr :
Anti-IL17F MAb, Biotin-Conjugated
Host animal :
Mouse
Clone :
5I2730
Official Symbol :
IL17F
Clonality :
Monoclonal
Application :
WB, IHC-P
Target :
IL17F
Species Reactivity :
Human
Conjugate :
Biotin
Antibody Type :
Primary Antibodies
Immunogen :
Recombinant full length Human IL17F.
Alternative Names :
IL17F; interleukin 17F; interleukin-17F; IL 17F; ML 1; ML1; IL-24; cytokine ML-1; mutant IL-17F; interleukin-24; ML-1; CANDF6; IL-17F;
UniProt ID :
Q96PD4
Antibody Isotype :
IgG1
Size :
100 μg
Storage :
Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
company information
Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments